2-(3-methyl-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-8-nitro-6-(trifluoromethyl)-4H-benzo[e][1,3]thiazin-4-one

ID: ALA5208588

PubChem CID: 168295240

Max Phase: Preclinical

Molecular Formula: C15H11F3N6O3S

Molecular Weight: 412.35

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1nnc2n1CCN(c1nc(=O)c3cc(C(F)(F)F)cc([N+](=O)[O-])c3s1)C2

Standard InChI:  InChI=1S/C15H11F3N6O3S/c1-7-20-21-11-6-22(2-3-23(7)11)14-19-13(25)9-4-8(15(16,17)18)5-10(24(26)27)12(9)28-14/h4-5H,2-3,6H2,1H3

Standard InChI Key:  CVUPJRFXCUZFKX-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
    1.7851    1.4040    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0695    0.9934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0695    0.1723    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7831   -0.2336    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4914    0.1771    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4914    0.9939    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3623   -0.2361    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3501    0.1758    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0559   -0.2380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0559   -1.0594    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3480   -1.4668    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3623   -1.0575    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3480   -2.2836    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7658   -1.4659    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4747   -1.0594    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4747   -0.2380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7658    0.1767    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7658    0.9935    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4732    1.4020    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0584    1.4020    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1814   -1.4688    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1801   -2.2858    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8890   -1.0603    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8890   -1.8773    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.0998    1.5388    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9569    2.2026    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.7695    2.2858    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8890    1.3273    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  3  4  1  0
  5  4  1  0
  1  6  1  0
  6  5  1  0
  3  7  1  0
  8  7  1  0
  8  9  1  0
 10  9  2  0
 11 10  1  0
  7 12  2  0
 12 11  1  0
 11 13  2  0
 14 10  1  0
 15 14  2  0
 16 15  1  0
 17 16  2  0
 17  9  1  0
 18 17  1  0
 18 19  2  0
 18 20  1  0
 21 15  1  0
 21 22  1  0
 21 23  1  0
 21 24  1  0
  6 25  1  0
  1 26  2  0
 26 27  1  0
 27 25  2  0
 25 28  1  0
M  CHG  2  18   1  20  -1
M  END

Alternative Forms

  1. Parent:

    ALA5208588

    ---

Associated Targets(non-human)

Mycolicibacterium vaccae (371 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 412.35Molecular Weight (Monoisotopic): 412.0565AlogP: 2.50#Rotatable Bonds: 2
Polar Surface Area: 107.05Molecular Species: NEUTRALHBA: 9HBD:
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 2.32CX LogP: 1.46CX LogD: 1.46
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.47Np Likeness Score: -1.93

References

1. Schieferdecker S, Bernal FA, Wojtas KP, Keiff F, Li Y, Dahse HM, Kloss F..  (2022)  Development of Predictive Classification Models for Whole Cell Antimycobacterial Activity of Benzothiazinones.,  65  (9.0): [PMID:35502994] [10.1021/acs.jmedchem.2c00098]

Source